Bath & Body Works (NYSE:BBWI) Price Target Lowered to $32.00 at Bank of America

Bath & Body Works (NYSE:BBWI) had its target price dropped by investment analysts at Bank of America from $40.00 to $32.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Bank of America‘s price target would indicate a potential upside of 102.71% from the company’s current price.

Several other research firms have also weighed in on BBWI. Wall Street Zen lowered Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Wells Fargo & Company dropped their target price on shares of Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, October 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, October 8th. UBS Group lowered their price target on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a research report on Friday, August 29th. Finally, Morgan Stanley upped their target price on Bath & Body Works from $40.00 to $43.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Eleven equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, Bath & Body Works has an average rating of “Moderate Buy” and a consensus target price of $37.77.

Bath & Body Works Trading Down 25.0%

Shares of BBWI traded down $5.25 during trading hours on Thursday, reaching $15.79. The company had a trading volume of 26,721,557 shares, compared to its average volume of 5,680,086. Bath & Body Works has a 12-month low of $15.63 and a 12-month high of $41.87. The firm has a 50 day simple moving average of $25.07 and a 200-day simple moving average of $28.34. The company has a market capitalization of $3.25 billion, a price-to-earnings ratio of 4.69, a PEG ratio of 0.86 and a beta of 1.53.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.05). The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company’s quarterly revenue was down 1.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.49 earnings per share. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. Sell-side analysts forecast that Bath & Body Works will post 3.3 earnings per share for the current year.

Institutional Investors Weigh In On Bath & Body Works

Several hedge funds have recently made changes to their positions in BBWI. Mutual of America Capital Management LLC boosted its stake in Bath & Body Works by 235.8% in the 1st quarter. Mutual of America Capital Management LLC now owns 111,471 shares of the company’s stock worth $3,380,000 after buying an additional 78,280 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Bath & Body Works during the 1st quarter worth about $807,000. Legato Capital Management LLC acquired a new stake in shares of Bath & Body Works in the first quarter worth approximately $663,000. Royce & Associates LP increased its position in Bath & Body Works by 22.8% during the first quarter. Royce & Associates LP now owns 40,423 shares of the company’s stock worth $1,226,000 after purchasing an additional 7,505 shares during the last quarter. Finally, Cetera Investment Advisers raised its stake in Bath & Body Works by 8.9% during the first quarter. Cetera Investment Advisers now owns 27,091 shares of the company’s stock worth $821,000 after purchasing an additional 2,214 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.